An 8-Week Randomized, Double-Blind, Parallel-Group, Multi-Center, Forced-Titration Study to Evaluate the Efficacy and Safety of Aliskiren Plus HCTZ Compared to Aliskiren Monotherapy in Metabolic Syndrome Patients With Stage 2 Hypertension.
Phase of Trial: Phase IV
Latest Information Update: 10 Mar 2011
At a glance
- Drugs Aliskiren; Hydrochlorothiazide
- Indications Isolated systolic hypertension
- Focus Therapeutic Use
- Acronyms AIMS
- 21 Jun 2010 Results presented at the 20th European Meeting on Hypertension.
- 06 Jan 2010 Actual end date (Jan 2010) added as reported by ClinicalTrials.gov.
- 06 Jan 2010 Actual patient number (532) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History